Rallybio's total assets for Q4 2024 were $68.11M, a decrease of -13.79% from the previous quarter. RLYB total liabilities were $6.45M for the fiscal quarter, a -21.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.